1,149
Participants
Start Date
April 22, 2021
Primary Completion Date
October 31, 2027
Study Completion Date
October 31, 2027
B. infantis
Activated B. infantis EVC001; Bifidobacterium longum subsp. infantis; 8 x 109 colony forming units (CFU) per day
Placebo
Lactose identical in appearance and taste to the active supplement
University Hospitals Leuven Faculty of Medicine, Catholic University of Leuven, Leuven
Universitätsklinikum Carl Gustav Carus Technische Universität Dresden, Dresden
AUF DER BULT, Kinder- und Jugendkrankenhaus, Hanover
Institute of Diabetes Research, Helmholtz Zentrum Munich, Germany, and Forschergruppe Diabetes, Technical University Munich (TUM), School of Medicine, Klinikum rechts der Isar, Munich
Department of Paediatrics Medical University of Warsaw, Warsaw
Lund University, Skane University Hospital SUS, Malmo
University Department of Paediatrics, Cambridge Biomedical Campus, Cambridge
Royal Victoria Infirmary, Newcastle upon Tyne, Newcastle
Technical University of Munich
OTHER
Kinderkrankenhaus auf der Bult
OTHER
University Hospital Carl Gustav Carus
OTHER
Skane University Hospital
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
Medical University of Warsaw
OTHER
Cambridge Biomedical Campus, Cambridge, UK
UNKNOWN
Royal Victoria Infirmary, Newcastle upon Tyne, UK
UNKNOWN
Helmholtz Zentrum München
INDUSTRY